Implementation of Intravenous Catheter Treatment to Prevent Phlebitis: A Cross-Sectional Study

  • Ida Ayu Md Vera Susiladewi Bali Mandara General Hospital, Bali, Indonesia
  • Ni Luh Maya Maheri Bali Mandara General Hospital, Bali, Indonesia
  • Ni Putu Emy Darma Yanti Nursing Management Department, School of Nursing, Faculty of Medicine, Udayana University, Indonesia
  • I Gusti Ngurah Putu Jaya Antara Bali Mandara General Hospital, Bali, Indonesia
Keywords: peripheral vein cannulation, phlebitis, prevention


Peripheral vein cannulation is commonly performed for rapid and accurate administration of medications. Phlebitis is the most common complication of intravenous catheter insertion. This study aims to investigate the implementation of intravenous catheter care to prevent phlebitis that was implied on a patient's cannulation conditions. This study was a cross sectional observational study conducted on patients at a hospital in Bali. Study conducted on 35 patients who were admitted to inpatient ward of the hospital in April 2022. The factors studied were age, gender, site of insertion, precision of dressing, dressing integrity, date on dressing, administration set integrity, date on administration set, and VIP score documentation. The results show that the mean age of the patient was 45.31 years old and 60% of the patients were men. 48,6% cannula was inserted in the movement area (wrist and ankle) while only 51,4% dressing was used properly so cannulation sites can be observed. All dressing were intact, dry and clean, but only 48.6% cannulation date documented on the dressing. Majority the administration sets were in good performance (94.3%) but there were only 31,4% with the installation date. The monitoring of peripheral vein cannulation using VIP score has not been widely applied (11,4%). Further intervention is needed to improve adherence to peripheral vein cannulation care so that phlebitis can be prevented optimally.


Abolfotouh, M. A., Salam, M., Bani Mustafa, A., White, D., & Balkhy, H. (2014). Prospective study of incidence and predictors of peripheral intravenous catheter-induced complications. Therapeutics and Clinical Risk Management, 993.

Atay, S., Sen, S., & Cukurlu, D. (2018). Phlebitis-related peripheral venous catheterization and the associated risk factors. Nigerian Journal of Clinical Practice, 21(7), 827–831.

Cicolini, G., Manzoli, L., Simonetti, V., Flacco, M. E., Comparcini, D., Capasso, L., di Baldassarre, A., & Eltaji Elfarouki, G. (2014). Phlebitis risk varies by peripheral venous catheter site and increases after 96 hours: a large multi‐centre prospective study. Journal of Advanced Nursing, 70(11), 2539–2549.

Guanche-Sicilia, A., Sánchez-Gómez, M. B., Castro-Peraza, M. E., Rodríguez-Gómez, J. Á., Gómez-Salgado, J., & Duarte-Clíments, G. (2021). Prevention and Treatment of Phlebitis Secondary to the Insertion of a Peripheral Venous Catheter: A Scoping Review from a Nursing Perspective. Healthcare, 9(5), 611.

Laudenbach, N., Carie A., B., Klaverkamp, L., & Hedman-Dennis, S. (2014). Peripheral IV Stabilization and the Rate of Complications in Children: An Exploratory Study. Journal of Pediatric Nursing, 29(4), 348–353.

Lopez, V., Molassiotis, A., Chan, W.-K., Ng, F., & Wong, E. (2004). An Intervention Study to Evaluate Nursing Management of Peripheral Intravascular Devices. Journal of Infusion Nursing, 27(5), 322–331.

Lulie, M., Tadesse, A., Tsegaye, T., Yesuf, T., & Silamsaw, M. (2021). Incidence of peripheral intravenous catheter phlebitis and its associated factors among patients admitted to University of Gondar hospital, Northwest Ethiopia: a prospective, observational study. Thrombosis Journal, 19(1), 48.

Mandal, A., & Raghu, K. (2019a). Study on incidence of phlebitis following the use of pherpheral intravenous catheter. Journal of Family Medicine and Primary Care, 8(9), 2827.

Mandal, A., & Raghu, K. (2019b). Study on incidence of phlebitis following the use of pherpheral intravenous catheter. Journal of Family Medicine and Primary Care, 8(9), 2827.

Nyika, M. L., Mukona, D., & Zvinavashe, M. (2018). Factors Contributing to Phlebitis Among Adult Patients Admitted in the Medical-Surgical Units of a Central Hospital in Harare, Zimbabwe. Journal of Infusion Nursing, 41(2), 96–102.

O’Grady, N. P., Alexander, M., Burns, L. A., Dellinger, P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., Raad, I. I., Randolph, A., Rupp, M. E., Saint, S., & Healthcare Infection Control Practices Advisory Committee (HICPAC). (2011). Intravascular Catheter-related Infection (BSI). Centre Disease Control and Prevention .

Ray‐Barruel, G., Polit, D. F., Murfield, J. E., & Rickard, C. M. (2014). Infusion phlebitis assessment measures: a systematic review. Journal of Evaluation in Clinical Practice, 20(2), 191–202.

Rickard, C. M., McCann, D., Munnings, J., & McGrail, M. R. (2010). Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Medicine, 8(1), 53.

Singh, A. K., Dwivedi, R., & Ghaharwar, A. P. S. (2018). Risk factors of thrombophlebitis at infusion sites in patients admitted in surgical ward: a prospective observational study. International Surgery Journal, 5(5), 1781.

Peripheral Intravenous Cannulation (PIVC) Insertion, Care and Removal (Adults), Pub. L. No. Trim No. T17/8996, 1 (2021).

Turnidge, J. (1984). Hazards of peripheral intravenous lines. Medical Journal of Australia, 141(1), 37–40.

Tzolos, E., & Salawu, A. (2014). Improving the frequency of visual infusion phlebitis (VIP) scoring on an oncology ward. BMJ Quality Improvement Reports, 3(1), u205455.w2364.

How to Cite
Md Vera Susiladewi IA, Maya Maheri NL, Yanti NPED, Ngurah Putu Jaya Antara IG. Implementation of Intravenous Catheter Treatment to Prevent Phlebitis: A Cross-Sectional Study. NHSJ [Internet]. 2023Mar.2 [cited 2023Mar.31];3(1):91-5. Available from: